ArticleMedical & biological engineering & computing2025
CTCNet: a fine-grained classification network for fluorescence images of circulating tumor cells.
Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- A hybrid compound scaling hypergraph neural network for robust cervical cancer subtype classification using whole slide cytology images.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The identification and categorization of circulating tumor cells (CTCs) in peripheral blood are imperative for advancing cancer diagnostics and prognostics. The intricacy of various CTCs subtypes, coupled with the difficulty in developing exhaustive datasets, has impeded progress in this specialized domain. To date, no methods have been dedicated exclusively to overcoming the classification challenges of CTCs. To address this deficit, we have developed CTCDet, a large-scale dataset meticulously annotated based on the distinctive pathological characteristics of CTCs, aimed at advancing the application of deep learning techniques in oncological research. Furthermore, we introduce CTCNet, an innovative hybrid architecture that merges the capabilities of CNNs and Transformers to achieve precise classification of CTCs. This architecture features the Parallel Token mixer, which integrates local window self-attention with large-kernel depthwise convolution, enhancing the network's ability to model intricate channel and spatial relationships. Additionally, the Deformable Large Kernel Attention (DLKAttention) module leverages deformable convolution and large-kernel operations to adeptly delineate the nuanced features of CTCs, substantially boosting classification efficacy. Comprehensive evaluations on the CTCDet dataset validate the superior performance of CTCNet, confirming its ability to outperform other general methods in accurate cell classification. Moreover, the generalizability of CTCNet has been established across various datasets, establishing its robustness and applicability. What is more, our proposed method can lead to clinical applications and provide some help in assisting cancer diagnosis and treatment. Code and Data are available at https://github.com/JasonWu404/CTCs_Classification .
Indexed as
Identifiers
39841310What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.